U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07169500) titled 'Autologous Transplantation Combined With BCMA CAR-T in the Treatment of Young NDMM' on July 31.
Brief Summary: To evaluate the safety and efficacy of autologous hematopoietic stem cell transplantation (ASCT) combined with BCMA-CART in the treatment of young NDMM
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Multiple Myeloma
Intervention:
BIOLOGICAL: CAR-T
Chimeric antigen receptor T cells (car-t) are genetically engineered MHC independent tumor specific killer cells.
Recruitment Status: RECRUITING
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Published by HT Digital Content Services ...